Therapeutic area intelligence for Pediatric Anxiety Disorders with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Gaze-Contingent →

Recent signals(1)

ClinicalJuly 23, 2026

Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety Trial Initiated

A clinical trial is underway to evaluate the effectiveness of gaze-contingent music reward therapy (GCMRT) combined with cognitive behavioral therapy (CBT) for children with anxiety disorders.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Pediatric Anxiety Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.